Cite
HARVARD Citation
Pontes, F. et al. (n.d.). 304PSurvival outcomes and survival predictors in recurrent and metastatic head and neck squamous cell cancer (R/M-HNSCC) patients treated with chemotherapy (CT) plus cetuximab as first-line therapy in a real-world study. Annals of oncology. p. . [Online].